deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT05406102

Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy

Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal : a Multicenter,Randomized Controlled Study

Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Conditions Anesthetics Anesthetics, Intravenous Drug Effect Psychotropic Drugs Recovery Safety
Interventions Propofol group Remimazolam
Updated 5 times since 2022 Last updated: Jun 28, 2022 Started: Jul 10, 2022 Primary completion: May 1, 2023 Completion: Jun 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Anesthetics and Anesthetics, Intravenous and is currently ongoing. First Affiliated Hospital Xi'an Jiaotong University leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Jan 2024 · 16 months · monthly snapshotNot Yet Recruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2024 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: Not Yet Recruiting → Unknown Status

  4. Sep 2022 — Jan 2024 [monthly]

    Not Yet Recruiting PHASE4

  5. Jul 2022 — Sep 2022 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • First Affiliated Hospital Xi'an Jiaotong University
Data source: First Affiliated Hospital Xi'an Jiaotong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations